Intellia Therapeutics NTLA
NASDAQ NTLA
$12.26 +0.14 (+1.11%)
As of: Oct 2, 2026 · 11:45 AM EDT

Intellia Therapeutics (NTLA) Long-Term Investments (2019 - 2026)

Updated

Intellia Therapeutics' Long-Term Investments came in at $190.6 million for Q2 2026, up 11.6% from $170.86 million a year earlier and up 34.9% from the prior quarter.

Analysis

Intellia Therapeutics (NTLA) Long-Term Investments (2019 - 2026) Analysis & Trends

At the end of FY2025, Intellia Therapeutics' Long-Term Investments was $155.25 million, down 40.3% from FY2024.

  • Long-Term Investments carries a five-year compound annual growth rate of 100.9% (FY2020 to FY2025).
  • Going back by year, Long-Term Investments was $260.22 million in FY2024 (+160.6%), $99.86 million in FY2023 (+44.0%), $69.34 million in FY2022 (-79.4%) and $337.36 million in FY2021.
  • The Q2 2026 figure represents the highest quarterly Long-Term Investments since Q1 2025.
  • Year-over-year, Long-Term Investments increased in four of the last eight quarters, with growth averaging 19.9%.
  • The fastest year-over-year change in Long-Term Investments over five years came in Q1 2022 (growth of 733.5%), and the weakest in Q3 2022 (a decline of 88.6%).
  • Business Quant data shows NTLA's Long-Term Investments at $141.26 million (Q1 2026), $155.25 million (Q4 2025) and $158.81 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Investments (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 266.00 Mn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 1.22 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 69.00 Mn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 2.62 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 1.56 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 5.79 Bn
10 Intellia Therapeutics 1.69 Bn 1.69 Bn - 190.60 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 190.60 Mn
Mar 31, 2026 141.26 Mn
Dec 31, 2025 155.25 Mn
Sep 30, 2025 158.81 Mn
Jun 30, 2025 170.86 Mn
Mar 31, 2025 203.35 Mn
Dec 31, 2024 260.22 Mn
Sep 30, 2024 286.57 Mn
Jun 30, 2024 248.81 Mn
Mar 31, 2024 162.09 Mn
Dec 31, 2023 99.86 Mn
Sep 30, 2023 137.75 Mn
Jun 30, 2023 164.01 Mn
Mar 31, 2023 225.04 Mn
Dec 31, 2022 69.34 Mn
Sep 30, 2022 40.10 Mn
Jun 30, 2022 45.62 Mn
Mar 31, 2022 139.49 Mn
Dec 31, 2021 337.36 Mn
Sep 30, 2021 350.45 Mn
API Access

Intellia Therapeutics Long-Term Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-investments&ticker=NTLA&period=max&api_key=YOUR_API_KEY